Prescription of anti-oedema agents and short-term mortality in older patients with acute ischaemic stroke

Drugs and Aging

Volumn 21, Issue 4, 2004, Pages 273-278

  Zuliani, Giovanni ^a   Cherubini, Antonio ^b   Atti, Anna Rita ^a   Ble, Alessandro ^a   Vavalle, Chella ^a   Di Todaro, Filippo ^a   Benedetti, Claudia ^b   Volpato, Stefano ^a   Marinescu, Maria Grazia ^a   Schena, Fabio ^a   Senin, Umberto ^b   Fellin, Renato ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; DEXAMETHASONE; GLYCEROL; MANNITOL; METHYLPREDNISOLONE; OSMOTIC AGENT;

AGED; ALCOHOL ABUSE; ANAMNESIS; ARTICLE; BLOOD ANALYSIS; BRAIN EDEMA; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; CLINICAL PRACTICE; CLINICAL TRIAL; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONGESTIVE HEART FAILURE; DEVELOPED COUNTRY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DRUG POTENTIATION; ELECTROCARDIOGRAM; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MORTALITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OUTCOMES RESEARCH; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SHORT COURSE THERAPY; SMOKING; STROKE; TRANSIENT ISCHEMIC ATTACK; URINALYSIS; VASCULAR DISEASE;

AGED; BRAIN EDEMA; CEREBROVASCULAR ACCIDENT; COHORT STUDIES; DIURETICS, OSMOTIC; DRUG THERAPY, COMBINATION; FEMALE; GLUCOCORTICOIDS; GLYCEROL; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MANNITOL; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 12144291707     PISSN: 1170229X     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002512-200421040-00005     Document Type: Article

References (24)

1. World Health Statistics Annual. Geneva: World Health Organisation, 1990, 1991, 1992
2. Guccione AA, Felson DT, Anderson JJ, et al. The effects of specific medical conditions on the functional limitations of elders in the Framingham study. Am J Public Health 1994; 84: 351-8
3. Ancheta JI, Reding MJ. Stroke diagnosis and treatment: a multidisciplinary effort. In: Hazzard WR, Blass JP, Ettinger Jr WH, et al., editors. Principles of geriatric medicine and gerontology. 4th ed. New York: McGraw-Hill, 1999: 1239-56
4. Iemolo F, Beghi E, Cavestro C, et al. Incidence, risk factors and short-term mortality of stroke in Vittoria, southern Italy. Neurol Sci 2002; 23: 15-21
5. Adams HP, Adams RJ, Brott T, et al. Guidelines for the early management of patients with ischemic stroke: a scientific statement from the stroke council of the American Heart Association. Stroke 2003; 934: 1056-83
6. Righetti E, Celani MG, Cantisani TA, et al. Glycerol for acute stroke: a Cochrane systematic review. J Neurol 2002; 249: 445-51
7. Bereczki D, Liu M, do Prado GF, et al. Mannitol for acute stroke. Cochrane Database Syst Rev 2001; (1): CD001153
8. Qizilbash N, Lewington SL, Lopez-Ameta JM. Corticosteroids for acute ischaemic stroke (Cochrane review). Cochrane Database Syst Rev 2002; (2): CD000064
9. Bamford J, Sandercock P, Dennis M, et al. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 1991; 337: 1521-6
10. Zuliani G, Cherubini A, Atti AR, et al. Low cholesterol levels are associated with short term mortality in older patients with ischemic stroke. J Geront Med Sci. In press
11. Garcia-Sola, Pulido P, Capilla P. The immediate and long-term effects of mannitol and glycerol: a comparative experimental study. Acta Neurochir (Wien) 1991; 109: 114-21
12. Kobayashi H, Ide H, Kodera T, et al. Effect of mannitol on focal ischemia evaluated by magnetic resonance imaging. Acta Neurochir Suppl 1994; 60: 228-30
13. Larsson O, Marinovich N, Barber K. Double-blind trial of glycerol therapy in early stroke. Lancet 1976; I: 832-4
14. Fawer R, Justfre JC, Berger JP. Intravenous glycerol in cerebral infarction: a crontrolled 4-month trial. Stroke 1978; 9: 484-6
15. Bayer AJ, Pathy MS, Newcombe R. Double-blind randomised trial of intravenous glycerol in acute stroke. Lancet 1987; I: 405-8
16. Yu YL, Kumana CR, Launder IJ, et al. Treatment of acute cortical infarct with intravenous glycerol: a double-blind, placebo-controlled randomized trial. Stroke 1993; 24: 1119-24
17. Bereczki D, Mihalka L, Szamatari S, et al. Mannitol use in acute stroke: case fatality at 30 days and 1 year. Stroke 2003; 34: 1730-5
18. Ohnishi T, Sher PB, Posner JB, et al. Capillary permeability factor secreted by malignant brain tumor: role in peritumoral brain edema and possible mechanism for antiedema effect of glucocorticoids. J Neurosurg 1990; 72: 245-51
19. Cairncross JG, Macdonald DR, Pexman JH, et al. Steroid-induced CT changes in patients with recurrent malignant glioma. Neurology 1988; 38: 724-6
20. Fishman RA. Steroids in the treatment of brain edema. N Engl J Med 1982; 306: 359-60
21. Norris JW, Hachinski VC. High dose steroid treatment in cerebral infarction. BMJ 1986; 292: 21-3
22. Alderson P, Roberts I. Corticosteroids in acute traumatic brain injury: systematic review of randomised controlled trials. BMJ 1997; 314: 1955-9
23. Stroke Prevention and Educational Awareness Diffusion (SPREAD) [online]. Available from URL: http:// www.spread.it [Accessed 2004 Jan 29]
24. Hartmann A, Rundek T, Mast H, et al. Mortality and acuses of death after first ischemic stroke: The Northern Manhattan Stroke Study. Neurology 2001; 57: 2000-5